Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
Vaccine|October 14, 2015
Nucleic acid (DNA) immunization as a platform for dengue vaccine developmentKevin R Porter, Kanakatte RaviprakashMethods in Molecular Medicine|September 22, 2006
Needle-free injection of DNA vaccines: a brief overview and methodologyKanakatte Raviprakash, Kevin R PorterCurrent Issues in Molecular Biology|November 11, 2016
DNA Vaccine Delivery and Improved ImmunogenicityKevin R Porter, Kanakatte RaviprakashMethods in Molecular Biology (Clifton, N.J.)|April 10, 2014
Tetravalent DNA vaccine product as a vaccine candidate against dengueKevin R Porter, Nimfa Teneza-Mora, Kanakatte RaviprakashVaccine|July 23, 2011
Development of dengue DNA vaccinesJanine R Danko, Charmagne G Beckett, Kevin R PorterClinical and Vaccine Immunology : CVI|December 17, 2009
Immunogenicity of a psoralen-inactivated dengue virus type 1 vaccine candidate in miceRyan C Maves, Roger M Castillo Oré, Kevin R Porter, et al.Methods in Molecular Biology (Clifton, N.J.)|May 13, 2022
Pseudovirus-Based Assays for the Measurement of Antibody-Mediated Neutralization of SARS-CoV-2Corey Balinsky, Vihasi Jani, Peifang Sun, et al.Journal of Virology|September 16, 2006
Characterization of antibody responses to combinations of a dengue virus type 2 DNA vaccine and two dengue virus type 2 protein vaccines in rhesus macaquesMonika Simmons, Kevin R Porter, Curtis G Hayes, et al.Vaccine|February 10, 2011
Immunogenicity and protective efficacy of a psoralen-inactivated dengue-1 virus vaccine candidate in Aotus nancymaae monkeysRyan C Maves, Roger M Castillo Oré, Kevin R Porter, et al.The Journal of Infectious Diseases|February 18, 2005
Cross-serotype neutralization of dengue virus in Aotus nancymae monkeysTadeusz J Kochel, Douglas M Watts, Alfonso S Gozalo, et al.Pageof 4